Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.020
-0.010 (-0.97%)
At close: May 12, 2025, 4:00 PM
0.9900
-0.0300 (-2.94%)
After-hours: May 12, 2025, 4:05 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $36.89 million as of May 12, 2025. Its market cap has decreased by -10.04% in one year.
Market Cap
36.89M
Enterprise Value
35.98M
1-Year Change
-10.04%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $36.89M, an increase of 1,975.21%. That is a compound annual growth rate of 227.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 37.25M | -14.20% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |